½ÃÀ庸°í¼­
»óǰÄÚµå
1598791

¿äµµ Ä«Å×ÅÍ ½ÃÀå : Á¦Ç° À¯Çü, ¿ëµµ, ¿ëµµ ¹× ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Urinary Catheter Market by Product (External Catheters, Foley or Indwelling Catheters, Intermittent Catheters), Type (Coated Catheters, Uncoated Catheters), Usage, Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿äµµ Ä«Å×ÅÍ ½ÃÀåÀº 2023³â 20¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2024³â¿¡´Â 22¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 9.30% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 38¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿äµµ Ä«Å×ÅÍ ½ÃÀå¿¡´Â ¿äÆó, ¼ö¼ú ÈÄ È¸º¹, ´Ù¹ß¼º °æÈ­Áõ, ô¼ö ¼Õ»ó, Àü¸³¼± Áúȯ°ú °°Àº ¸¸¼ºÁúȯÀ¸·Î ÀÎÇØ ¹æ±¤¿¡¼­ ¼Òº¯À» ÀÚ¿¬ÀûÀ¸·Î ¹èÃâÇÒ ¼ö ¾ø´Â »ç¶÷µéÀ» À§ÇØ ¼³°èµÈ ÀÇ·á±â±â°¡ Æ÷ÇԵ˴ϴÙ. ¿äµµ Ä«Å×ÅÍÀÇ Çʿ伺Àº º´¿ø, Àå±â ¿ä¾ç ½Ã¼³, ÀçÅà °£È£ µî ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ ¿äµµ Ä«Å×ÅͰ¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â µ¥¼­ ±âÀÎÇÕ´Ï´Ù. ¿äµµ Ä«Å×ÅÍÀÇ ¿ëµµ´Â ´Ü¼øÇÑ ¹è´¢»Ó¸¸ ¾Æ´Ï¶ó ¿ä¿ªµ¿ÇÐ °Ë»ç¿Í °°Àº Áø´Ü¿ë, Åõ¾à°ú °°Àº Ä¡·á¿ë±îÁö È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃÖÁ¾»ç¿ëÀڷδ º´¿ø, Ŭ¸®´Ð, Àå±â¿ä¾ç¼¾ÅÍ, ÀçÅÃÀÇ·á Á¦°øÀÚ µîÀÌ ÀÖ½À´Ï´Ù. ¼¼°è Àα¸ÀÇ °í·ÉÈ­, ºñ´¢±â Áúȯ ¹× ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, Ä«Å×ÅÍ ±â¼úÀÇ ¹ßÀü, ÀÇ·áºñ ÁöÃâ Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¿ä·Î°¨¿°(UTI) À§Çè, ȯÀÚÀÇ ºÒÆíÇÔ, ¼÷·ÃµÈ °£È£»çÀÇ Çʿ伺, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç µîÀÇ µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀÇ ±âȸ´Â °¨¿°À» ÁÙÀ̱â À§ÇÑ Ç×±Õ ÄÚÆÃ Ä«Å×ÅÍ °³¹ß, ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× µ¥ÀÌÅÍ ¼öÁýÀ» À§ÇÑ ½º¸¶Æ® ±â¼ú ÅëÇÕ, ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ã۱â À§ÇÑ »ýüÀûÇÕ¼º Àç·áÀÇ ¹ßÀü¿¡ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃÖ¼Òħ½ÀÀû »ðÀÔ ±â¼ú°ú ¸ÂÃãÇü Ä«Å×ÅÍ Ä¡·á¹ý¿¡ ÃÊÁ¡À» ¸ÂÃá ¿¬±¸µµ °í·ÁÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÅÈï±¹ ½ÃÀåÀº ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±°ú ÀÎÁöµµ Çâ»óÀ¸·Î ÀÎÇØ À¯¸®ÇÑ ºñÁî´Ï½º ±âȸ¸¦ ´©¸®°í ÀÖÀ¸¸ç, ¼±Áø±¹ ½ÃÀåÀº ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ¸¦ °è¼ÓÇϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ±â°ü°úÀÇ Àü·«Àû ÆÄÆ®³Ê½Ê°ú ¸ÂÃãÇü ±³À° ÇÁ·Î±×·¥Àº ±â¾÷ÀÌ ½ÃÀå ÀÔÁö¸¦ È®´ëÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÀϺΠÁö¿ª¿¡¼­´Â ºñ¿ë Á¦¾à°ú »óȯ ¹®Á¦°¡ ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ±â¾÷Àº ºñ¿ë È¿À²ÀûÀÎ »ý»ê°ú ¸íÈ®ÇÑ °¡Ä¡ Á¦¾È¿¡ ÃÊÁ¡À» ¸ÂÃß°í ³Î¸® º¸±ÞÇØ¾ß ÇÕ´Ï´Ù. ½ÃÀå °æÀïÀÌ Ä¡¿­Çϰí Á¦Ç° Çõ½Å°ú ±ÔÁ¦ ±âÁØ Áؼö°¡ Áß¿äÇϱ⠶§¹®¿¡ Áö¼Ó°¡´ÉÇÑ ¼ºÀåÀ» À§Çؼ­´Â źźÇÑ R&D ÅõÀÚ¿Í Àü·«Àû ¸¶ÄÉÆÃ Àü·«ÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 20¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 22¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 38¾ï 9,000¸¸ ´Þ·¯
CAGR(%) 9.30%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¿äµµ Ä«Å×ÅÍ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¿äµµ Ä«Å×ÅÍ ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ¿ä½Ç±ÝÀÇ À¯º´·ü Áõ°¡
    • Àü ¼¼°è ¿Ü°ú ¼ö¼ú °Ç¼ö Áõ°¡
    • Àü¸³¼±¾ÏÀÇ ³ôÀº ¹ßº´·ü°ú À¯¸®ÇÑ »óȯ ½Ã³ª¸®¿À
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • Ä«Å×ÅÍ Ä¡·á¿¡ µû¸¥ ÇÕº´Áõ
  • ½ÃÀå ±âȸ
    • ÀÇ»çµéÀÇ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Å×Ç÷Ð, ½Ç¸®ÄÜ ¿¤¶ó½ºÅä¸Ó, Ç×±ÕÁ¦·Î ÄÚÆÃµÈ »ðÀÔ Ä«Å×ÅÍ ¶Ç´Â Æú¸® Ä«Å×ÅÍ °³¹ß
  • ½ÃÀå °úÁ¦
    • ¿ä½Ç±Ý¿¡ ´ëÇÑ ´ëü Ä¡·á ¿É¼ÇÀÇ ÀÌ¿ë °¡´É¼º

Porter's Five Forces : ¿äµµ Ä«Å×ÅÍ ½ÃÀåÀ» Ž»öÇϱâÀ§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¿äµµ Ä«Å×ÅÍ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¿äµµ Ä«Å×ÅÍ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¿äµµ Ä«Å×ÅÍ ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

¿äµµ Ä«Å×ÅÍ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¿äµµ Ä«Å×ÅÍ ½ÃÀå¿¡¼­ÀÇ °ø±Þ¾÷ü ½ÇÀû Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¿äµµ Ä«Å×ÅÍ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿äµµ Ä«Å×ÅÍ ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ ¿äµµ Ä«Å×ÅÍ ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æ ã±â

¿äµµ Ä«Å×ÅÍ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¿äµµ Ä«Å×ÅÍ ½ÃÀå : Á¦Ç°º°

  • ¿ÜºÎ Ä«Å×ÅÍ
  • Æú¸® Ä«Å×ÅÍ ¶Ç´Â À¯Ä¡ Ä«Å×ÅÍ
  • °£Çæ Ä«Å×ÅÍ

Á¦7Àå ¿äµµ Ä«Å×ÅÍ ½ÃÀå : À¯Çüº°

  • ÄÚÆÃ Ä«Å×ÅÍ
  • ÄÚÆÃ µÇ¾î ÀÖÁö ¾ÊÀº Ä«Å×ÅÍ

Á¦8Àå ¿äµµ Ä«Å×ÅÍ ½ÃÀå ¿ëµµº°

  • ¿©¼º¿ë ¿äµµ Ä«Å×ÅÍ
  • ³²¼º¿ë ¿äµµ Ä«Å×ÅÍ

Á¦9Àå ¿äµµ Ä«Å×ÅÍ ½ÃÀå : ¿ëµµº°

  • ¾ç¼º Àü¸³¼± ºñ´ëÁõ
  • ô¼ö ¼Õ»ó
  • ¿ä½Ç±Ý

Á¦10Àå ¿äµµ Ä«Å×ÅÍ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ±¸±Þ Áø·á¼Ò
  • º´¿ø
  • Àå±â°£º´ ½Ã¼³

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ ¿äµµ Ä«Å×ÅÍ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿äµµ Ä«Å×ÅÍ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿äµµ Ä«Å×ÅÍ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦14Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • B. Braun Melsungen AG
  • Bactiguard AB
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast A/S
  • ConvaTec Group
  • Cook Group Incorporated
  • Go Medical Industries Pty Ltd.
  • Hollister Incorporated
  • HR Pharmaceuticals, Inc.
  • Medline Industries, Inc.
  • Medtronic PLC
  • Ribbel International Limited
  • Teleflex Incorporated
  • Urocare Products, Inc.
  • Well Lead Medical Co., Ltd.
ksm 24.11.29

The Urinary Catheter Market was valued at USD 2.09 billion in 2023, expected to reach USD 2.28 billion in 2024, and is projected to grow at a CAGR of 9.30%, to USD 3.89 billion by 2030.

The urinary catheter market encompasses medical devices designed for the drainage of urine from the bladder in individuals unable to do so naturally due to medical conditions like urinary retention, post-surgical recovery, or chronic illnesses such as multiple sclerosis, spinal cord injuries, or prostate disorders. The necessity for urinary catheters is driven by their critical role in several healthcare settings, including hospitals, long-term care facilities, and home care. Their applications extend beyond mere urine drainage to diagnostic applications, such as urodynamic testing, and therapeutic uses, like administration of medication. Key end-users include hospitals, clinics, long-term care centers, and home healthcare providers. The market's growth is influenced by an aging global population, increasing prevalence of urinary and chronic diseases, advancements in catheter technology, and increased healthcare expenditure. However, the market faces challenges such as risk of urinary tract infections (UTIs), patient discomfort, skilled nursing requirements, and stringent regulatory requirements. Innovation opportunities lie in developing antimicrobial-coated catheters to reduce infections, integrating smart technology for real-time monitoring and data collection, and advancing biocompatible materials to enhance patient comfort. Further research could focus on minimal-invasive insertion techniques and personalized catheterization procedures. Emerging markets present lucrative opportunities due to improving healthcare infrastructure and increasing awareness, while developed markets continue to invest in advanced healthcare technologies. Strategic partnerships with healthcare institutions and tailored training programs can help companies expand their market presence. However, cost constraints and reimbursement issues in certain regions may hinder market expansion. Therefore, companies should focus on cost-effective production and clear value propositions to ensure broad adoption. The market's nature is highly competitive, with a significant focus on product innovation and adherence to regulatory standards, demanding robust R&D investment and strategic marketing initiatives for sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 2.09 billion
Estimated Year [2024] USD 2.28 billion
Forecast Year [2030] USD 3.89 billion
CAGR (%) 9.30%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Urinary Catheter Market

The Urinary Catheter Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing Prevalence of Urinary Incontinence
    • Increasing Number of Surgical Procedures across the Globe
    • High Incidence of Prostate Cancer along with the Favorable Reimbursement Scenario
  • Market Restraints
    • Complications Associated with Catheterization
  • Market Opportunities
    • Development of Indwelling or Foley Catheters Coated with Teflon, Silicon Elastomer, and Antimicrobial Agents to Meet Increasing Physician Demand
  • Market Challenges
    • Availability of Alternative Treatment Options for Urinary Incontinence

Porter's Five Forces: A Strategic Tool for Navigating the Urinary Catheter Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Urinary Catheter Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Urinary Catheter Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Urinary Catheter Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Urinary Catheter Market

A detailed market share analysis in the Urinary Catheter Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Urinary Catheter Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Urinary Catheter Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Urinary Catheter Market

A strategic analysis of the Urinary Catheter Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Urinary Catheter Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Bactiguard AB, Becton, Dickinson and Company, Boston Scientific Corporation, Coloplast A/S, ConvaTec Group, Cook Group Incorporated, Go Medical Industries Pty Ltd., Hollister Incorporated, HR Pharmaceuticals, Inc., Medline Industries, Inc., Medtronic PLC, Ribbel International Limited, Teleflex Incorporated, Urocare Products, Inc., and Well Lead Medical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Urinary Catheter Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across External Catheters, Foley or Indwelling Catheters, and Intermittent Catheters.
  • Based on Type, market is studied across Coated Catheters and Uncoated Catheters.
  • Based on Usage, market is studied across Female Urinary Catheters and Male Urinary Catheters.
  • Based on Application, market is studied across Benign Prostate Hyperplasia, Spinal Cord Injury, and Urinary Incontinence.
  • Based on End-User, market is studied across Emergency Clinics, Hospitals, and Long-Term Care Facilities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Prevalence of Urinary Incontinence
      • 5.1.1.2. Increasing Number of Surgical Procedures across the Globe
      • 5.1.1.3. High Incidence of Prostate Cancer along with the Favorable Reimbursement Scenario
    • 5.1.2. Restraints
      • 5.1.2.1. Complications Associated with Catheterization
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of Indwelling or Foley Catheters Coated with Teflon, Silicon Elastomer, and Antimicrobial Agents to Meet Increasing Physician Demand
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of Alternative Treatment Options for Urinary Incontinence
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Urinary Catheter Market, by Product

  • 6.1. Introduction
  • 6.2. External Catheters
  • 6.3. Foley or Indwelling Catheters
  • 6.4. Intermittent Catheters

7. Urinary Catheter Market, by Type

  • 7.1. Introduction
  • 7.2. Coated Catheters
  • 7.3. Uncoated Catheters

8. Urinary Catheter Market, by Usage

  • 8.1. Introduction
  • 8.2. Female Urinary Catheters
  • 8.3. Male Urinary Catheters

9. Urinary Catheter Market, by Application

  • 9.1. Introduction
  • 9.2. Benign Prostate Hyperplasia
  • 9.3. Spinal Cord Injury
  • 9.4. Urinary Incontinence

10. Urinary Catheter Market, by End-User

  • 10.1. Introduction
  • 10.2. Emergency Clinics
  • 10.3. Hospitals
  • 10.4. Long-Term Care Facilities

11. Americas Urinary Catheter Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Urinary Catheter Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Urinary Catheter Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Melsungen AG
  • 2. Bactiguard AB
  • 3. Becton, Dickinson and Company
  • 4. Boston Scientific Corporation
  • 5. Coloplast A/S
  • 6. ConvaTec Group
  • 7. Cook Group Incorporated
  • 8. Go Medical Industries Pty Ltd.
  • 9. Hollister Incorporated
  • 10. HR Pharmaceuticals, Inc.
  • 11. Medline Industries, Inc.
  • 12. Medtronic PLC
  • 13. Ribbel International Limited
  • 14. Teleflex Incorporated
  • 15. Urocare Products, Inc.
  • 16. Well Lead Medical Co., Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦